RUS
Details
| Name | Pharmsintez |
| Placement specification | common stock |
| Placement type | IPO |
| Subscription type | Public offering |
| Start of placement | 19.10.2010 |
| Status | Completed |
| End of placement | 24.11.2010 |
| Placement amount | 23 000 000 |
| Placement volume, mln. USD | 17 |
| Upper bound, USD | 0.90 |
| Lower bound, USD | 0.67 |
| Trading floor | MICEX |
| Investment banks | ALOR INVEST, Finam, IT Invest - PROSPECT, OTKRITIE Financial Corporation , Veles Capital |
| Country of operation | Russia |
| Industry | Pharmaceutical industry |
| Offering Memorandum |
Issuer
Pharmsynthez is an innovative pharmaceutical company developing new medications, technologies of drugs for organ-specific delivery and innovative methods of manufacture for pharmaceutical ingredients. The company has at its disposal a research and production facility.
Web-site: to the issuer site
Issuer news
-
06.05.2026
Cbonds: Ethos Technologies (LIFE) Earnings Preview: Innovation & Headwinds
-
17.08.2021
Cbonds: Farmsintez announces about RAS net loss for 6 months of 2021 equal to RUB -41.37 million. Total revenue’s increase is 256.9%
-
06.04.2021
Cbonds: Farmsintez announces increased RAS net profit for 2020, up 60.45 % YoY
-
13.04.2020
Cbonds: Farmsintez’s 4 Q 2019 Y RAS results were published
-
01.02.2019
Cbonds: Human Stem Cell Institute’s, Eurofinance-Nedvizhimost’s, Diod’s, Farmsintez’s IFRS results were published
Stock details
| Stock | Farmsintez |
| Type | common stock |
| Par value, RUB | 5 |
| State registration number | 1-02-09669-J |
| ISIN | RU000A0JR514 |
| Announced volume | 301 010 754 |
MICEX
Ticker:
LIFE
Quotation list:
Âíåñïèñî÷íûå öåííûå áóìàãè
RTS
Ticker:
LIFE
Quotation list:
Âíåñïèñî÷íûå öåííûå áóìàãè
MICEX
Ticker:
LIFE
Quotation list:
RTS
Ticker:
LIFE
Quotation list:
Price dynamics
| MICEX | RTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 | ||||||||||||||||||||||||||||||||||
| Dividends | ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||